Design Therapeutics, Inc.DSGNNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank67
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-7.71
↑ 93% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive declineElevated
Average
-105.86
Historical baseline
PeriodValueYoY Change
2025-7.71-9.4%
2024-7.04-217.3%
2023-2.22+75.4%
2022-9.03+67.4%
2021-27.68+79.7%
2020-136.25+75.3%
2019-551.11-